The purpose of this study is to determine the impact of varying doses of artesunate on
treatment outcome and whether higher doses of artesunate can overcome the problem of
compromised artemisinin sensitivity in the region.
To determine the safety and tolerability of this previously untested experimental high dose
(6 mg/Kg/D X 7 day, total 42 mg/Kg) artesunate monotherapy regimen.
Phase:
N/A
Details
Lead Sponsor:
Armed Forces Research Institute of Medical Sciences, Thailand
Collaborators:
Bill and Melinda Gates Foundation World Health Organization